Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug‐tolerant bacteria

AK Ojha, AD Baughn, D Sambandan… - Molecular …, 2008 - Wiley Online Library
AK Ojha, AD Baughn, D Sambandan, T Hsu, X Trivelli, Y Guerardel, A Alahari, L Kremer
Molecular microbiology, 2008Wiley Online Library
Successful treatment of human tuberculosis requires 6–9 months' therapy with multiple
antibiotics. Incomplete clearance of tubercle bacilli frequently results in disease relapse,
presumably as a result of reactivation of persistent drug‐tolerant Mycobacterium
tuberculosis cells, although the nature and location of these persisters are not known. In
other pathogens, antibiotic tolerance is often associated with the formation of biofilms–
organized communities of surface‐attached cells–but physiologically and genetically …
Summary
Successful treatment of human tuberculosis requires 6–9 months' therapy with multiple antibiotics. Incomplete clearance of tubercle bacilli frequently results in disease relapse, presumably as a result of reactivation of persistent drug‐tolerant Mycobacterium tuberculosis cells, although the nature and location of these persisters are not known. In other pathogens, antibiotic tolerance is often associated with the formation of biofilms – organized communities of surface‐attached cells – but physiologically and genetically defined M. tuberculosis biofilms have not been described. Here, we show that M. tuberculosis forms biofilms with specific environmental and genetic requirements distinct from those for planktonic growth, which contain an extracellular matrix rich in free mycolic acids, and harbour an important drug‐tolerant population that persist despite exposure to high levels of antibiotics.
Wiley Online Library